Gene expression profiling in T-cell acute lymphoblastic leukemia.

[1]  S. Armstrong,et al.  Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. , 2003, Blood.

[2]  A. Zapata,et al.  The role of morphogens in T-cell development. , 2003, Trends in immunology.

[3]  J. Whitlock,et al.  Disruption of the RanBP17/Hox11L2 region by recombination with the TCRδ locus in acute lymphoblastic leukemias with t(5;14)(q34;q11) , 2002, Leukemia.

[4]  Thomas A Milne,et al.  MLL targets SET domain methyltransferase activity to Hox gene promoters. , 2002, Molecular cell.

[5]  S. Korsmeyer,et al.  The role of MLL in hematopoiesis and leukemia , 2002, Current opinion in hematology.

[6]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[7]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[8]  R. Heilig,et al.  A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia , 2001, Leukemia.

[9]  R. Gelber,et al.  Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.

[10]  A. Ferrando,et al.  Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. , 2000, Seminars in hematology.

[11]  W. Hiddemann,et al.  Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. , 2000, Blood.

[12]  P. D. de Jong,et al.  The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Look,et al.  Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study , 1999, Leukemia.

[14]  C. Begley,et al.  The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. , 1996, The EMBO journal.

[15]  F. Alt,et al.  The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic Lineages , 1996, Cell.

[16]  S. Korsmeyer,et al.  Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.

[17]  M. Sofroniew,et al.  The Hox11 gene is essential for cell survival during spleen development. , 1995, Development.

[18]  M. Amylon,et al.  Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. , 1995, Blood.

[19]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[20]  C. C. Bailey,et al.  Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X , 1995, The Lancet.

[21]  J. Li,et al.  Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. , 1994, The EMBO journal.

[22]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[23]  S. Korsmeyer,et al.  Hox11 controls the genesis of the spleen , 1994, Nature.

[24]  C. Bloomfield,et al.  Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemia. , 1992 .

[25]  R. Espinosa,et al.  TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Kamel‐Reid,et al.  A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .

[27]  W. Ludwig,et al.  TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.

[28]  S. Korsmeyer,et al.  Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.

[29]  F. Behm,et al.  Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy , 1991, The Lancet.

[30]  R. Berger,et al.  Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T‐cell leukemias , 1990, Genes, chromosomes & cancer.

[31]  M. Cleary,et al.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.

[32]  P. Nowell,et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Korsmeyer,et al.  The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.

[34]  R. Baer,et al.  Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia? , 1997, Current topics in microbiology and immunology.